New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 9, 2014
11:51 EDTAVP, FTNT, SRPT, STX, MBI, LL, GNC, INFN, OREXOptions with increasing implied volatility:
Options with increasing implied volatility: LL SRPT OREX MBI FTNT INFN STX AVP GNC
News For LL;SRPT;OREX;MBI;FTNT;INFN;STX;AVP;GNC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
November 24, 2014
12:21 EDTSRPTBioMarin rises after agreeing to buy DMD drug maker Prosensa
Subscribe for More Information
10:00 EDTLLOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Aruba Networks (ARUN) upgraded to Outperform from Market Perform at Raymond James... Banco Bilbao (BBVA) upgraded to Neutral from Underperform at BofA/Merrill... Berry Plastics (BERY) upgraded to Outperform from Market Perform at BMO Capital... Denny's (DENN) upgraded to Buy from Neutral at Janney Capital... Hess Corp. (HES) upgraded to Outperform from Market Perform at Raymond James... Huaneng Power (HNP) upgraded to Buy from Neutral at BofA/Merrill... Infoblox (BLOX) upgraded to Buy from Hold at Needham... Kate Spade (KATE) upgraded at BofA/Merrill... Lumber Liquidators (LL) upgraded to Overweight from Equal Weight at Morgan Stanley... Occidental Petroleum (OXY) upgraded to Strong Buy from Outperform at Raymond James... PT Indosat (IIT) upgraded to Buy from Neutral at Nomura... Silvercorp Metals (SVM) upgraded to Outperform from Market Perform at Raymond James... Toro Company (TTC) upgraded to Buy from Neutral at Longbow... United Microelectronics (UMC) upgraded to Market Perform from Underperform at Bernstein.
09:23 EDTSRPT, LLOn The Fly: Pre-market Movers
Subscribe for More Information
09:20 EDTSRPTProsensa buyout not good for Sarepta, says Piper Jaffray
Piper Jaffray says it views the Prosensa (RNA) acquisition by BioMarin (BMRN) as bad for Sarepta (SRPT) since the company now has to compete with a "significantly more experienced and better funded orphan drug player." Piper adds that the takeover announced this morning has no impact on Sarepta's current drug filing process for its Duchenne muscular dystrophy drug eteplirsen. It keeps a Neutral rating on Sarepta with a $20 price target. The stock is trading up 9% in pre-market trading to $17.16 after BioMarin paid a healthy premium to acquire its peer Prosensa.
08:12 EDTSRPTSarepta rises after DMD competitor acquired at significant premium
Shares of Sarepta Therapeutics (SRPT) are up 9.5% to $17.23 in early pre-market trading after rival drugmaker Prosensa (RNA) agreed to be acquired by BioMarin (BMRN). BioMarin has offered to purchase all of the outstanding ordinary shares of Prosensa for $17.75 per share, for a total up front consideration of approximately $680M. In addition, two approximately $80M contingent milestones are payable for the approval of drisapersen in the U.S. and Europe. Drisapersen is Prosensa's lead exon-skipping drug candidate for treating Duchenne muscular dystrophy, or DMD. Sarepta is at work on eteplirsen, its own exon-skipping therapeutic candidate for the treatment of DMD. Prosensa closed trading Friday at $11.44 and are up about 65% to $18.90 in pre-market trading following the deal announcement.
07:30 EDTGNCSterne Agee to hold a conference
4th Annual Philadelphia SMID Cap Conference is being held in Philadelphia on November 24.
06:15 EDTLLLumber Liquidators upgraded to Overweight from Equal Weight at Morgan Stanley
Morgan Stanley upgraded Lumber Liquidators to Overweight with an $85 price target. The firm believes gross margin worries are overdone and 2014 comp declines should be a bottom. Morgan Stanley's checks indicate non-weather regions are healthy with mid single digit comp growth and weather impacted regions have improved since August.
November 21, 2014
09:17 EDTOREXOn The Fly: Pre-market Movers
Subscribe for More Information
08:10 EDTOREXOrexigen announces allowance of new U.S. patent for Contrave
Orexigen Therapeutics announced that the company has received a notice of allowance from the U.S. Patent and Trademark Office for U.S. Patent Application No. 11/757,773, which covers use of Orexigen's sustained release formulation of naltrexone, which was designed to improve drug tolerability for Contrave in a method for treating obesity. The patent is expected to expire in March of 2028. Orexigen expects the patent to be listed in the Orange Book maintained by the FDA.
November 20, 2014
15:14 EDTSRPTTraveler returned from Mali being tested for Ebola in NYC, Daily News reports
Subscribe for More Information
11:05 EDTFTNTStephens hosts a conference call with Fortinet
Conference call with CEO Xie and CFO Del Matto is being held on November 21 at 2 pm.
07:19 EDTFTNTUBS to hold a conference
Subscribe for More Information
November 19, 2014
16:31 EDTAVPOn The Fly: Closing Wrap
Subscribe for More Information
07:40 EDTSTXUBS to hold a conference
Global Technology Conference to be held in Sausalito, California on November 18-20 with webcasted company presentations to begin on November 19 at 10:45 am; not all company presentations may be webcasted.Webcast Link
November 18, 2014
17:09 EDTAVPAvon Products announces actions to reduce costs including headcount reductions
Subscribe for More Information
09:17 EDTSRPTSarepta announces first patient dosed in Eteplirsen study
Subscribe for More Information
08:02 EDTSTXSeagate announces reseller agreement with SGI
Subscribe for More Information
November 17, 2014
08:44 EDTSRPTNebraska Medical announces death of third Ebola patient
The Nebraska Medical Center said via Twitter, "We are sorry to announce that the 3rd Ebola patient, Dr. Martin Salia, has passed away as a result of the advanced symptoms of the disease." Drug companies that are working on experimental Ebola vaccines or treatments include Peregrine (PPHM), Tekmira (TKMR), Sarepta (SRPT), BioCryst (BCRX), Chimerix (CMRX) and NewLink Genetics (NLNK). Some companies that offer protective clothing and waste disposal include Lakeland Industries (LAKE), Alpha Pro Tech (APT) and Sharps Compliance (SMED).
06:48 EDTFTNTState Department hacked, NY Times reports
Subscribe for More Information
November 14, 2014
10:03 EDTAVPHigh option volume stocks
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use